Plopii is a biotechnology company focusing on drug patents and consumer wellness products built around paraxanthine, the primary active metabolite of caffeine. Founded by Michael Tolmach (CEO) and David Alexander (COO) in Brooklyn, NY, Plopii has filed three USPTO patent applications covering paraxanthine-based formulations across nootropic pouches, cognitive energy drinks, and a next-generation OTC headache pill. Explore the science, view our patent filings, or shop our products.